Assessment of the in vitro Efficacy of the Novel Antimicrobial Peptide CECT7121 against Human Gram-Positive Bacteria from Serious Infections Refractory to Treatment

Publisher： Karger

E-ISSN： 1421-9794|55|4|270-277

ISSN： 0009-3157

Source： Chemotherapy, Vol.55, Iss.4, 2009-06, pp. : 270-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro Interaction between Ofloxacin and Cefotaxime against Gram-Positive and Gram-Negative Bacteria Involved in Serious Infections

By  

Chemotherapy, Vol. 44, Iss. 2, 1998-03 ,pp. : 94-98

Karger

Access to resources Recommend Favorite

In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria

By Oh Sang-Hun   Kim Josep   Baek Sung-Yoon   Chae Sang-Eun   Park Hee-Soo   Cho Young-Lag   Kwak Jin-Hwan  

Molecules, Vol. 22, Iss. 3, 2017-03 ,pp. : 394-394

MDPI

Access to resources Recommend Favorite

Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria

By Nawrocki Kathryn L.   Crispell Emily K.   McBride Shonna M.  

Antibiotics, Vol. 3, Iss. 4, 2014-10 ,pp. : 461-492

MDPI

Access to resources Recommend Favorite

Activity of Nadifloxacin (OPC-7251) and Seven Other Antimicrobial Agents against Aerobic and Anaerobic Gram-Positive Bacteria Isolated from Bacterial Skin Infections

By  

Chemotherapy, Vol. 50, Iss. 4, 2004-10 ,pp. : 196-201

Karger

Access to resources Recommend Favorite

In vitro Activity of Levofloxacin against Gram-Positive Bacteria

By  

Chemotherapy, Vol. 45, Iss. 6, 1999-11 ,pp. : 411-417

Karger

Access to resources Recommend Favorite